Telepatia
AI NativeTransforming healthcare with invisible clinical intelligence. Built by doctors, for doctors.
Published Oct 9, 2026
Telepatia’s differentiation (based on available evidence)
Where competitors may have advantages
Pricing comparison (what’s known)
Market adoption trends (context)
—
| Aspect | Telepatia | Abridge | Microsoft Nuance DAX Copilot |
|---|---|---|---|
| Starting Price | Not publicly disclosed; vendor states a free tier for independent physicians but does not disclose limits | Not publicly disclosed; enterprise contracts | Not publicly disclosed; enterprise contracts |
| Best For | Providers and payers in Latin America seeking an integrated scribe + CDSS + BI offering across heterogeneous systems | Large health systems, particularly those with Epic, seeking deep ambient documentation | Large enterprises invested in Microsoft/Nuance ecosystems requiring enterprise-grade distribution and integration |
| Key Strength | Vendor presents a combined suite (scribe + CDSS + integration + BI) and emphasizes regional/localization for LatAm markets | Documented Epic alignment and enterprise-scale deployments in some markets | Enterprise distribution and integration strength by virtue of Microsoft/Nuance ecosystem and procurement posture |
| Key Weakness | Limited publicly accessible independent reviews and limited publicly documented formal security attestations; pricing transparency is limited | Sales-gated pricing and implementation complexity; may be more suitable for very large systems | Sales-gated pricing; workflow fit and cost may vary by specialty and organizational standardization |